{"success":true,"data":{"pressRelease":{"id":"66515","rtpr_id":"nPn5lLfgMa","ticker":"MMED","exchange":"NASDAQ","all_tickers":["MMED"],"title":"MiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.","author":"PR Newswire","published_at":"2026-06-17T13:04:00.047Z","article_body":"MiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.\n\nPR Newswire\n\nNORTHRIDGE, Calif., June 17, 2026\n\nPeople with type 1 or insulin-requiring type 2 diabetes in the U.S. can now\nwear MiniMed's smallest pump, paired with the Simplera Sync™ sensor\n\nNORTHRIDGE, Calif., June 17, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED),\ntoday announced its first commercial launch of the MiniMed Flex™ system in\nthe United States — its first app-controlled pump and the company's smallest\ninsulin pump yet. The system launches with Simplera Sync™ sensor, a\ndisposable, all-in-one sensor with easy two-step insertion. The launch with\nthe Instinct sensor, made by Abbott, will follow later this summer.*\n\nFor years, people who use insulin pumps have had to think about where and how\nthey wear their device each day. While diabetes technology has advanced, many\nstill had to choose between clinical performance and a pump that works with\ntheir lifestyle. Few products have offered both.\n\nDesigned to let diabetes take a backseat, the MiniMed Flex™ system gives\npeople the freedom to live on their own terms without sacrificing the clinical\nperformance they depend on. About half the size** of other MiniMed pumps, it's\nthe company's most compact pump while still holding 300 units of insulin. It\nis engineered to fit into everyday life no matter what a person wants to wear.\n\n\"For too long, people managing diabetes have had to choose between effective\ntherapy and the freedom to just live their lives. MiniMed Flex™ changes\nthat,\" said Que Dallara, chief executive officer of MiniMed. \"It's small\nenough to disappear, smart enough to handle the hard work, and now it's in\npeople's hands. This is the MiniMed we're becoming — faster, and more\nfocused than ever on delivering on our Mission. Better days start now.\"\n\nThe MiniMed Flex™ system is powered by MiniMed's most advanced SmartGuard™\nalgorithm — the only system with Meal Detection™ technology that detects\nrapid rises in sensor glucose and delivers a correction dose for occasional\nmissed meal boluses or underestimated carb counts.(§) Working seamlessly in\nthe background, the system continuously adjusts and autocorrects insulin\ndelivery up to every 5 minutes(‡) based on real-time glucose readings from\nthe Simplera Sync™ sensor, helping users spend more time in their target\nrange with less daily effort. Real-world results have demonstrated 80% Time in\nRange (TIR)¹ with recommended settings — exceeding worldwide TIR\nrecommendations.(◊) Compatible with MiniMed's Extended™ infusion set,\nusers can also benefit from up to seven days of wear and up to 96% fewer\ninjections compared to traditional insulin therapy. (Δ)\n\n\"Having worked with people using MiniMed Flex™, I've seen firsthand how app\ncontrol can simplify everyday diabetes management,\" said Anders Carlson, MD,\nexecutive director, International Diabetes Center, and director,\nHealthPartners diabetes program; assistant professor, University of Minnesota\nMedical School. \"For many patients, two devices are central to daily life:\ntheir automated insulin delivery system and their phone. Bringing those\nexperiences together, while continuing to leverage the trusted MiniMed\nalgorithm, represents a meaningful evolution in how diabetes technology can\nsupport people throughout the day.\"\n\nThe MiniMed Flex™ system is FDA cleared for people with type 1 diabetes ages\n7 years and older, as well as adults ages 18 years and older with\ninsulin-requiring type 2 diabetes.\n\nReimbursement support and access programs are available through MiniMed's\ncustomer support team. For more information and to order MiniMed Flex™ visit\nminimed.com/en-us/products/minimed-flex-system\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4713498-1&h=2000458073&u=http%3A%2F%2Fwww.minimed.com%2Fen-us%2Fproducts%2Fminimed-flex-system&a=minimed.com%2Fen-us%2Fproducts%2Fminimed-flex-system)\n.\n\nAbout MiniMed\nMiniMed is a global leader in insulin delivery, constantly advancing therapies\nthat support people with diabetes in 80 countries. Our full-stack, integrated\necosystem, including our insulin delivery systems, CGMs, algorithms, and\neasy-to-use app experience, is designed to work seamlessly together, supported\nby white-glove, wrap-around service. For over 40 years, we've pioneered\ntherapies people can rely on by anticipating needs, reducing burden, and\nhelping make life with diabetes easier. Our mission is to make every day a\nbetter day for people with diabetes.\n\nAny forward-looking statements are subject to risks and uncertainties such as\nthose described in MiniMed's periodic reports on file with the Securities and\nExchange Commission. Actual results may differ materially from anticipated\nresults.\n\nReferences\n\n 1. Arrieta A, et al. Diabetes Obes Metab. 2022;10.1111/dom.14714 .\n*MiniMed Flex™ system with Instinct sensor is investigational. Not cleared\nby the FDA for any use and not commercially available in the U.S.\n\n**Compared to MiniMed™ 780G pump\n\n§Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar\nlevels under control after eating.\n\n‡Refers to SmartGuard(TM) feature. Individual results may vary.\n\n◊Due to inherent real-world study limitations, caution is advised when\nattempting to extrapolate these results to new patients. There could be\nsignificant differences.\n\nΔAssumes 4 injections per day for 30 days and one infusion set change every\nseven days.\n\n \n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/minimeds-smallest-app-controlled-insulin-pump-is-now-available-in-the-us-302802777.html\n(https://www.prnewswire.com/news-releases/minimeds-smallest-app-controlled-insulin-pump-is-now-available-in-the-us-302802777.html)\n\nSOURCE MiniMed\n\n\n\nJanet Cho, Global Communications, +1 (818) 403-7028, Ryan Weispfenning, Investor Relations, +1 (763) 505-4626\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1811575/MEDTRONIC-FLEX-SIMPLERA-PHONE-LGT-A.jpg?id=OA2721732\nhttps://mmx.prnewswire.com/media/MS1867622/MiniMed_Flex_Shipment_Launch_2.jpg?id=OA2721752\nhttps://mmx.prnewswire.com/media/MS1867623/MiniMed_Flex_Shipment_Launch.jpg?id=OA2721754\nhttps://mmx.prnewswire.com/media/MS1803182/Minimed-logo-line-rgb-blue--3_Logo.jpg?id=OA2721731\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn5lLfgMa","title":"MiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.","author":"PR Newswire","ticker":"MMED","created":"2026-06-17T13:04:00.047Z","tickers":["MMED"],"exchange":"NASDAQ","article_body":"MiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.\n\nPR Newswire\n\nNORTHRIDGE, Calif., June 17, 2026\n\nPeople with type 1 or insulin-requiring type 2 diabetes in the U.S. can now\nwear MiniMed's smallest pump, paired with the Simplera Sync™ sensor\n\nNORTHRIDGE, Calif., June 17, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED),\ntoday announced its first commercial launch of the MiniMed Flex™ system in\nthe United States — its first app-controlled pump and the company's smallest\ninsulin pump yet. The system launches with Simplera Sync™ sensor, a\ndisposable, all-in-one sensor with easy two-step insertion. The launch with\nthe Instinct sensor, made by Abbott, will follow later this summer.*\n\nFor years, people who use insulin pumps have had to think about where and how\nthey wear their device each day. While diabetes technology has advanced, many\nstill had to choose between clinical performance and a pump that works with\ntheir lifestyle. Few products have offered both.\n\nDesigned to let diabetes take a backseat, the MiniMed Flex™ system gives\npeople the freedom to live on their own terms without sacrificing the clinical\nperformance they depend on. About half the size** of other MiniMed pumps, it's\nthe company's most compact pump while still holding 300 units of insulin. It\nis engineered to fit into everyday life no matter what a person wants to wear.\n\n\"For too long, people managing diabetes have had to choose between effective\ntherapy and the freedom to just live their lives. MiniMed Flex™ changes\nthat,\" said Que Dallara, chief executive officer of MiniMed. \"It's small\nenough to disappear, smart enough to handle the hard work, and now it's in\npeople's hands. This is the MiniMed we're becoming — faster, and more\nfocused than ever on delivering on our Mission. Better days start now.\"\n\nThe MiniMed Flex™ system is powered by MiniMed's most advanced SmartGuard™\nalgorithm — the only system with Meal Detection™ technology that detects\nrapid rises in sensor glucose and delivers a correction dose for occasional\nmissed meal boluses or underestimated carb counts.(§) Working seamlessly in\nthe background, the system continuously adjusts and autocorrects insulin\ndelivery up to every 5 minutes(‡) based on real-time glucose readings from\nthe Simplera Sync™ sensor, helping users spend more time in their target\nrange with less daily effort. Real-world results have demonstrated 80% Time in\nRange (TIR)¹ with recommended settings — exceeding worldwide TIR\nrecommendations.(◊) Compatible with MiniMed's Extended™ infusion set,\nusers can also benefit from up to seven days of wear and up to 96% fewer\ninjections compared to traditional insulin therapy. (Δ)\n\n\"Having worked with people using MiniMed Flex™, I've seen firsthand how app\ncontrol can simplify everyday diabetes management,\" said Anders Carlson, MD,\nexecutive director, International Diabetes Center, and director,\nHealthPartners diabetes program; assistant professor, University of Minnesota\nMedical School. \"For many patients, two devices are central to daily life:\ntheir automated insulin delivery system and their phone. Bringing those\nexperiences together, while continuing to leverage the trusted MiniMed\nalgorithm, represents a meaningful evolution in how diabetes technology can\nsupport people throughout the day.\"\n\nThe MiniMed Flex™ system is FDA cleared for people with type 1 diabetes ages\n7 years and older, as well as adults ages 18 years and older with\ninsulin-requiring type 2 diabetes.\n\nReimbursement support and access programs are available through MiniMed's\ncustomer support team. For more information and to order MiniMed Flex™ visit\nminimed.com/en-us/products/minimed-flex-system\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4713498-1&h=2000458073&u=http%3A%2F%2Fwww.minimed.com%2Fen-us%2Fproducts%2Fminimed-flex-system&a=minimed.com%2Fen-us%2Fproducts%2Fminimed-flex-system)\n.\n\nAbout MiniMed\nMiniMed is a global leader in insulin delivery, constantly advancing therapies\nthat support people with diabetes in 80 countries. Our full-stack, integrated\necosystem, including our insulin delivery systems, CGMs, algorithms, and\neasy-to-use app experience, is designed to work seamlessly together, supported\nby white-glove, wrap-around service. For over 40 years, we've pioneered\ntherapies people can rely on by anticipating needs, reducing burden, and\nhelping make life with diabetes easier. Our mission is to make every day a\nbetter day for people with diabetes.\n\nAny forward-looking statements are subject to risks and uncertainties such as\nthose described in MiniMed's periodic reports on file with the Securities and\nExchange Commission. Actual results may differ materially from anticipated\nresults.\n\nReferences\n\n 1. Arrieta A, et al. Diabetes Obes Metab. 2022;10.1111/dom.14714 .\n*MiniMed Flex™ system with Instinct sensor is investigational. Not cleared\nby the FDA for any use and not commercially available in the U.S.\n\n**Compared to MiniMed™ 780G pump\n\n§Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar\nlevels under control after eating.\n\n‡Refers to SmartGuard(TM) feature. Individual results may vary.\n\n◊Due to inherent real-world study limitations, caution is advised when\nattempting to extrapolate these results to new patients. There could be\nsignificant differences.\n\nΔAssumes 4 injections per day for 30 days and one infusion set change every\nseven days.\n\n \n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/minimeds-smallest-app-controlled-insulin-pump-is-now-available-in-the-us-302802777.html\n(https://www.prnewswire.com/news-releases/minimeds-smallest-app-controlled-insulin-pump-is-now-available-in-the-us-302802777.html)\n\nSOURCE MiniMed\n\n\n\nJanet Cho, Global Communications, +1 (818) 403-7028, Ryan Weispfenning, Investor Relations, +1 (763) 505-4626\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1811575/MEDTRONIC-FLEX-SIMPLERA-PHONE-LGT-A.jpg?id=OA2721732\nhttps://mmx.prnewswire.com/media/MS1867622/MiniMed_Flex_Shipment_Launch_2.jpg?id=OA2721752\nhttps://mmx.prnewswire.com/media/MS1867623/MiniMed_Flex_Shipment_Launch.jpg?id=OA2721754\nhttps://mmx.prnewswire.com/media/MS1803182/Minimed-logo-line-rgb-blue--3_Logo.jpg?id=OA2721731\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-06-17T13:04:00.094160112Z","server_sent_at_ms":1781701440094},"received_at":"2026-06-17T13:04:00.163Z","source_url":"https://www.prnewswire.com/news-releases/minimeds-smallest-app-controlled-insulin-pump-is-now-available-in-the-us-302802777.html"},"analysis":{"id":"55931","press_release_id":"66515","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":[],"eventType":"product_launch","narrative":"MiniMed announced the U.S. commercial launch of the MiniMed Flex system, its smallest and first app-controlled insulin pump, paired initially with the Simplera Sync sensor.\n\nThe system features the advanced SmartGuard algorithm with Meal Detection technology and is FDA cleared for people with Type 1 diabetes ages seven and older and adults with insulin-requiring Type 2 diabetes.\n\nReal-world results indicate the device achieves 80% Time in Range and can reduce injections by up to 96% compared to traditional therapy, while holding 300 units of insulin.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"MiniMed Flex launches in the U.S. as the company's smallest, app-connected insulin pump."},"keyFigures":{"customDimensions":{"time_in_range_percent":80,"insulin_capacity_units":300,"injection_reduction_percent":96}},"quotedText":"It's small enough to disappear, smart enough to handle the hard work, and now it's in people's hands.","namedEntities":{"people":[{"name":"Que Dallara","role":"Chief Executive Officer"},{"name":"Anders Carlson","role":"Executive Director, International Diabetes Center"}],"products":["MiniMed Flex™ system","Simplera Sync™ sensor","Instinct sensor","SmartGuard™ algorithm","Extended™ infusion set","MiniMed™ 780G pump"],"companies":[{"name":"MiniMed","ticker":"MMED"},{"name":"Abbott","relationship":"sensor manufacturer"}],"dollarAmounts":[]},"materialImpact":{"score":4,"reasoning":"Commercial launch of the flagship MiniMed Flex system, the company's smallest and first app-controlled insulin pump, marking a significant product refresh and revenue driver now available in the U.S."},"tickerRelevance":{"others":[],"primary":"MMED"},"globalImportance":35,"audienceRelevance":45,"eventTypeSecondary":[],"importanceComponents":{"eventGravity":"major_product_launch","sectorWeight":"medical_devices","marketCapAdjustment":"mid_cap"}},"event_type":"product_launch","event_type_secondary":null,"sentiment":"bullish","material_impact_score":4,"narrative":"MiniMed announced the U.S. commercial launch of the MiniMed Flex system, its smallest and first app-controlled insulin pump, paired initially with the Simplera Sync sensor.\n\nThe system features the advanced SmartGuard algorithm with Meal Detection technology and is FDA cleared for people with Type 1 diabetes ages seven and older and adults with insulin-requiring Type 2 diabetes.\n\nReal-world results indicate the device achieves 80% Time in Range and can reduce injections by up to 96% compared to traditional therapy, while holding 300 units of insulin.","key_figures":{"customDimensions":{"time_in_range_percent":80,"insulin_capacity_units":300,"injection_reduction_percent":96}},"named_entities":{"people":[{"name":"Que Dallara","role":"Chief Executive Officer"},{"name":"Anders Carlson","role":"Executive Director, International Diabetes Center"}],"products":["MiniMed Flex™ system","Simplera Sync™ sensor","Instinct sensor","SmartGuard™ algorithm","Extended™ infusion set","MiniMed™ 780G pump"],"companies":[{"name":"MiniMed","ticker":"MMED"},{"name":"Abbott","relationship":"sensor manufacturer"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-17T13:46:58.764Z","global_importance":35,"audience_relevance":45,"importance_components":{"eventGravity":"major_product_launch","sectorWeight":"medical_devices","marketCapAdjustment":"mid_cap"}},"durationMs":128076,"modelName":"george-droid-qwen-72b"}}